A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

“With low uptake of PrEP among the communities most impacted by HIV, this insurance coverage requirement with ... The new ...

From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

2024 — Scientists have identified promising real-world links between common HIV drugs and a reduced incidence of Alzheimer's ... Scientists Identify Pro-Aging 'Sugar Signature' in the Blood of ...

Historically, as mentioned, PrEP has been used to treat cisgender gay men, especially in light of the HIV crisis of the 1980s ...

In recent years the option to purchase medications from India has gained significant popularity offering a reliable and affordable solution for people worldwide India has emerged as a trusted source f ...

Researchers looked at 198 kidney transplants performed at hospitals across the United States. They found similar results ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...

Gilead Sciences, Inc. GILD recently announced additional efficacy, safety and demographic data from its late-stage study on lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, for the ...

ViiV Healthcare, a company specialising in HIV treatment and prevention, yesterday announced that it will provide at least ...